Literature DB >> 1975517

A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation.

A A Geisterfer-Lowrance1, S Kass, G Tanigawa, H P Vosberg, W McKenna, C E Seidman, J G Seidman.   

Abstract

A point mutation in exon 13 of the beta cardiac myosin heavy chain (MHC) gene is present in all individuals affected with familial hypertrophic cardiomyopathy (FHC) from a large kindred. This missense mutation converts a highly conserved arginine residue (Arg-403) to a glutamine. Affected individuals from an unrelated family lack this missense mutation, but instead have an alpha/beta cardiac MHC hybrid gene. Identification of two unique mutations within cardiac MHC genes in all individuals with FHC from two unrelated families demonstrates that defects in the cardiac MHC genes can cause this disease. The pathology resulting from a missense mutation at residue 403 further suggests that a critical function of myosin is disrupted by this mutation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1975517     DOI: 10.1016/0092-8674(90)90274-i

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  361 in total

Review 1.  Molecular genetics of cardiomyopathies.

Authors:  G Shah; R Roberts
Journal:  J Nucl Cardiol       Date:  2000 Mar-Apr       Impact factor: 5.952

2.  Functional diversity between orthologous myosins with minimal sequence diversity.

Authors:  M Canepari; R Rossi; M A Pellegrino; R Bottinelli; S Schiaffino; C Reggiani
Journal:  J Muscle Res Cell Motil       Date:  2000-05       Impact factor: 2.698

3.  Mutation of the myosin converter domain alters cross-bridge elasticity.

Authors:  Jan Köhler; Gerhard Winkler; Imke Schulte; Tim Scholz; William McKenna; Bernhard Brenner; Theresia Kraft
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

4.  On genetic and phenotypic variability of hypertrophic cardiomyopathy: nature versus nurture.

Authors:  A J Marian
Journal:  J Am Coll Cardiol       Date:  2001-08       Impact factor: 24.094

5.  Crystal structure of the motor domain of a class-I myosin.

Authors:  Martin Kollmar; Ulrike Dürrwang; Werner Kliche; Dietmar J Manstein; F Jon Kull
Journal:  EMBO J       Date:  2002-06-03       Impact factor: 11.598

Review 6.  Modifier genes for hypertrophic cardiomyopathy.

Authors:  A J Marian
Journal:  Curr Opin Cardiol       Date:  2002-05       Impact factor: 2.161

Review 7.  Athlete"s heart and hypertrophic cardiomyopathy.

Authors:  A Pelliccia
Journal:  Curr Cardiol Rep       Date:  2000-03       Impact factor: 2.931

Review 8.  The molecular genetic basis for hypertrophic cardiomyopathy.

Authors:  A J Marian; R Roberts
Journal:  J Mol Cell Cardiol       Date:  2001-04       Impact factor: 5.000

9.  Desensitization of myofilaments to Ca2+ as a therapeutic target for hypertrophic cardiomyopathy with mutations in thin filament proteins.

Authors:  Marco L Alves; Fernando A L Dias; Robert D Gaffin; Jillian N Simon; Eric M Montminy; Brandon J Biesiadecki; Aaron C Hinken; Chad M Warren; Megan S Utter; Robert T Davis; Sadayappan Sakthivel; Jeffrey Robbins; David F Wieczorek; R John Solaro; Beata M Wolska
Journal:  Circ Cardiovasc Genet       Date:  2014-02-28

Review 10.  The Myofilament Field Revisited in the Age of Cellular and Molecular Biology.

Authors:  Sakthivel Sadayappan
Journal:  Circ Res       Date:  2017-09-01       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.